EUVIMEDObjevte EUVIMED
Fallbericht

Transcatheter aortic valve replacement‐related aortic dissection: A clinical case series

Takashi Hiruma iD, Ryosuke Higuchi, Mike Saji, Itaru Takamisawa, Tomoki Shimokawa, Mamoru Nanasato

Catheterization and Cardiovascular Interventions · 2023-02 · 101 (3) · 668-675

DOI: 10.1002/ccd.30574 ↗

At a glance

Fallbericht in Catheterization and Cardiovascular Interventions, published online on 2023-01-26. Written by Takashi Hiruma and 5 co-authors. Institution: Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. Major MEDLINE topics: Aortic Dissection, Aortic Valve Stenosis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Cited 16 times so far (Crossref); 26 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objectives

We review our experience with 13 periprocedural aortic dissection (AD) cases caused by transcatheter aortic valve replacement (TAVR).

Background

AD is a potentially lethal complication of TAVR; however, only sporadic case reports have been published to date.

Methods

Among 1335 consecutive patients who underwent TAVR in 2013–2021, we retrospectively extracted 13 patients (1.0%) with TAVR‐related AD (Stanford type A in 6 [46%], type B in 7 [54%]). AD was defined as a new‐onset dissected layer of the aortic wall and diagnosed by aortography, computed tomography, or transesophageal echocardiography.

Results

Five of the six type A AD cases (83%) were detected during TAVR versus only one of the seven type B AD cases (14%). Four of the seven type B AD cases (57%) were asymptomatic and incidentally detected on computed tomography. The presumed causes of AD were injury by the delivery sheath (39%), delivery catheter (23%), valve implantation (15%), stent edge (15%), and pre‐dilation balloon (8%). Complicated AD occurred in only one patient (8%). Considering the patient's age and prohibitive surgical risk, all patients were treated conservatively and free of any aortic‐related deaths or interventions during a follow‐up of 1087 days.

Conclusions

TAVR‐related AD is a rare but life‐threatening condition that may be underdiagnosed. Its optimal therapy remains unclear, and conservative management might be an option for selected patients. Further studies are needed to elucidate the incidence, risk factors, effective screening, optimal therapy, and outcomes of TAVR‐related AD.

Subjects

MeSH terms (MEDLINE)

Aortic DissectionAortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementHumansAortic ValveRetrospective StudiesRisk FactorsTreatment Outcome

Author keywords

TAVIaortic dissectionaortic injuryvascular complication

Authors and institutions

  • Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
  • Department of Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan.

ORCID profiles: Takashi Hiruma

Cite

APA

Hiruma, T., Higuchi, R., Saji, M., Takamisawa, I., Shimokawa, T., & Nanasato, M. (2023). Transcatheter aortic valve replacement‐related aortic dissection: A clinical case series. Catheterization and Cardiovascular Interventions, 101(3), 668-675. https://doi.org/10.1002/ccd.30574

Vancouver

Hiruma T, Higuchi R, Saji M, Takamisawa I, Shimokawa T, Nanasato M. Transcatheter aortic valve replacement‐related aortic dissection: A clinical case series. Catheterization and Cardiovascular Interventions. 2023;101(3):668-675. doi:10.1002/ccd.30574

BibTeX
@article{Hiruma2023,
  author = {Hiruma, Takashi and Higuchi, Ryosuke and Saji, Mike and Takamisawa, Itaru and Shimokawa, Tomoki and Nanasato, Mamoru},
  title = {Transcatheter aortic valve replacement‐related aortic dissection: A clinical case series},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  volume = {101},
  number = {3},
  pages = {668--675},
  doi = {10.1002/ccd.30574}
}
Start for free →